Brief: HLS Says Vascepa Reported To Reduce Coronary Plaque In Evaporate Study Final Results

HLS Therapeutics

31/08/2020 11:33

Aug 31 (Reuters) - HLS Therapeutics Inc  HLS.TO :
    * VASCEPA® (ICOSAPENT ETHYL) REPORTED TO SIGNIFICANTLY
REDUCE
CORONARY PLAQUE IN EVAPORATE STUDY FINAL RESULTS PRESENTED AT
ESC CONGRESS 2020
    * HLS THERAPEUTICS INC - PRIMARY ENDPOINT OF SLOWED CORONARY
PLAQUE PROGRESSION REPORTED TO HAVE BEEN MET WITH VASCEPA

Source text for Eikon:  ID:nCNWPsZtNa 
Further company coverage:  HLS.TO 

 ((Reuters.Briefs@thomsonreuters.com;))